Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
Perit Dial Int. 2012 May-Jun;32(3):322-31. doi: 10.3747/pdi.2011.00084. Epub 2011 Dec 1.
The adjusted 5-year survival for dialysis patients in the United States is 33%-35%, and patients treated with peritoneal dialysis (PD) have a high risk of transfer to hemodialysis (HD). No data are available on the effect of neighborhood characteristics or regional differences on the outcomes of PD patients in the United States.
We analyzed the relationships of selected patient demographics, socio-economic characteristics of the dialysis unit's neighborhood, "rurality," and geographic location with transfer to HD and with a composite outcome of transfer to HD or death, for all PD patients in the United States who, between 2004 and 2009, used supplies manufactured by Baxter Healthcare (n = 58 700).
Over a median follow-up of 18.7 months, 29% of patients transferred to HD (median time to HD transfer: 49 months), and 54% reached the composite outcome. More than 20% of the events occurred within the first 90 days of PD start. The risk for each of the study outcomes was higher for patients who had received any previous treatment with HD, for those treated in units located in areas with a higher proportion of black residents, and for those living in remote rural areas. Furthermore, the risk for reaching either of the study outcomes was consistently lower for patients treated in units located in California, Alaska, Hawaii, Guam, the Mariana Islands, and American Samoa.
We observed significant regional differences in the outcomes of PD patients in the United States that have not previously been reported. Understanding the differences in clinical practice that underlie these regional differences might help to further improve PD outcomes.
美国透析患者的调整后 5 年生存率为 33%-35%,接受腹膜透析 (PD) 治疗的患者有很高的风险转为血液透析 (HD)。目前尚无关于美国 PD 患者的居住环境特征或地区差异对其治疗结果影响的数据。
我们分析了美国所有接受 Baxter Healthcare 生产的 PD 用品治疗的 PD 患者的特定患者人口统计学特征、透析单位所在社区的社会经济特征、“农村”和地理位置与转为 HD 以及转为 HD 或死亡复合结果之间的关系,患者数据来源于 2004 年至 2009 年期间的资料(n = 58700)。
在中位随访 18.7 个月期间,29%的患者转为 HD(转为 HD 的中位时间:49 个月),54%的患者达到复合结果。超过 20%的事件发生在 PD 开始后的前 90 天内。与研究结果中的任何一项相关的风险都更高,其发生在那些有过 HD 治疗史的患者中、在那些接受来自黑人居民比例较高地区的单位治疗的患者中、以及在那些居住在偏远农村地区的患者中。此外,与研究结果中的任何一项相关的风险对于那些在加利福尼亚州、阿拉斯加、夏威夷州、关岛、马里亚纳群岛和美属萨摩亚州接受治疗的患者来说都较低。
我们观察到美国 PD 患者的治疗结果存在显著的地区差异,这些差异以前尚未被报道过。了解这些地区差异背后的临床实践差异可能有助于进一步提高 PD 的治疗结果。